-
-
-
-
-
-
-
Baird Starts Abbott Labs (ABT) at Outperform, 'Set to Improve with Catalysts Ahead'
-
-
-
-
-
-
-
Abbott Reports First-Quarter 2026 Results; Updates Guidance to Reflect Acquisition of Exact Sciences
-
-
-
-
-
-
-
Abbott Reports Fourth-Quarter and Full-Year 2025 Results; Issues 2026 Financial Outlook
-
-
-
-
-
-
-
Abbott Reports Third-Quarter 2025 Results and Reaffirms Full-Year Guidance
-
-
-
-
-
-
-
UBS: Time to cut back on cyclicals, favor select defensives
-
-
-
-
-
-
-
Piper Sandler Highlights Top Medtech Picks and Catalyst-Rich Names
-
-
-
-
-
-
-
Abbott backs profit forecast, to invest $500 million in US amid tariffs
-
1,219,403 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

